Products
Latest News
FAQ
Log in
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
4
clinical trials
|
View Analysis
Sort by:
Newest First
Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells
Phase 2
Not yet recruiting
Conditions
Gastric Cancer
Interventions
Drug: Camrelizumab Nab-Paclitaxel S-1
Subscribe
First Posted Date
2022-06-08
Last Posted Date
2022-06-24
Lead Sponsor
Hebei Medical University
Target Recruit Count
30
Registration Number
NCT05410847
Subscribe
A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells
Phase 2
Conditions
Gastric Cancer With Positive Exfoliative Cancer Cells
Interventions
Drug: apatinib
Drug: paclitaxel
Drug: S-1
Subscribe
First Posted Date
2018-10-24
Last Posted Date
2018-10-31
Lead Sponsor
Hebei Medical University
Target Recruit Count
36
Registration Number
NCT03718624
Subscribe
A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells
Phase 2
Conditions
Gastric Cancer
Interventions
Drug: paclitaxel apatinib S-1
Subscribe
First Posted Date
2018-02-09
Last Posted Date
2018-02-09
Lead Sponsor
Hebei Medical University
Target Recruit Count
38
Registration Number
NCT03428425
Subscribe
Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells
Phase 2
Conditions
Gastric Cancer
Interventions
Drug: Apatinib
Subscribe
First Posted Date
2015-07-29
Last Posted Date
2017-10-09
Lead Sponsor
Hebei Medical University
Target Recruit Count
48
Registration Number
NCT02510469
Locations
🇨🇳
Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy